The GSK IMPACT Awards are an annual programme, funded by GlaxoSmithKline (GSK) as part of the company’s commitment to promote community health and wellbeing. The awards have been running since 1997 and are organised and managed in partnership with The King’s Fund, a leading independent health charity working to improve health and social care.
The 2026 GSK IMPACT Awards are open to registered charities that are at least three years old, working in a health-related field in the UK, with a total annual income between £150,000 and £3 million.
This year:
- Up to ten winners will receive £40,000, in unrestricted funding with the overall winner receiving an additional £10,000
- Up to five runners-up will receive £4,000 in unrestricted funding
- Award winners are offered free training and development valued at an average of £13,500 for each organisation and pro bono offers from GSK including 12 months of legal support
Eligible charities must:
- Have existed for a minimum of three years by 20 August 2025
- Have a total annual income of between £150,000 and £3 million as shown in their most recent accounts
- Be independently constituted from any national umbrella organisation
- Target community health needs in the UK. Community can be defined as a geographical community or a community of interest
- Have a track record of achievement in community health issues
The Awards recognise excellence in existing work and do not seek to fund new projects.
Deadline for stage one applications: 20th August 2025, 5pm
Topics